CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
46.29
-0.97 (-2.05%)
At close: Nov 21, 2024, 4:00 PM
46.40
+0.11 (0.24%)
After-hours: Nov 21, 2024, 5:09 PM EST
CRISPR Therapeutics AG Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$73.69
Upside
+59.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $53 | Hold | Reiterates | $53 | +14.50% | Nov 6, 2024 |
| Barclays | Barclays | Hold Maintains $59 → $55 | Hold | Maintains | $59 → $55 | +18.82% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $84 | Strong Buy | Reiterates | $84 | +81.46% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $60 → $53 | Hold | Maintains | $60 → $53 | +14.50% | Oct 4, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $120 → $100 | Strong Buy | Maintains | $120 → $100 | +116.03% | Aug 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 8, 2024 |
| Stifel | Stifel | Hold Maintains $60 → $59 | Hold | Maintains | $60 → $59 | +27.46% | Aug 6, 2024 |
| Barclays | Barclays | Hold Maintains $67 → $59 | Hold | Maintains | $67 → $59 | +27.46% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $66 → $60 | Hold | Maintains | $66 → $60 | +29.62% | Aug 6, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $112 → $94 | Strong Buy | Maintains | $112 → $94 | +103.07% | Aug 6, 2024 |
| Needham | Needham | Strong Buy Maintains $88 → $84 | Strong Buy | Maintains | $88 → $84 | +81.46% | Aug 6, 2024 |
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jun 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $88 | Strong Buy | Reiterates | $88 | +90.11% | Jun 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $105 | Buy | Reiterates | $105 | +126.83% | Jun 17, 2024 |
| Needham | Needham | Strong Buy Reiterates $88 | Strong Buy | Reiterates | $88 | +90.11% | Jun 17, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $89 → $84 | Strong Buy | Maintains | $89 → $84 | +81.46% | May 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.